RGEBX
Price
$82.89
Change
+$0.45 (+0.55%)
Updated
Sep 8 closing price
Net Assets
332.38B
TWUIX
Price
$106.58
Change
-$0.29 (-0.27%)
Updated
Sep 5 closing price
Net Assets
26.44B
Interact to see
Advertisement

RGEBX vs TWUIX

Header iconRGEBX vs TWUIX Comparison
Open Charts RGEBX vs TWUIXBanner chart's image
American Funds Growth Fund of Amer R2E
Price$82.89
Change+$0.45 (+0.55%)
VolumeN/A
Net Assets332.38B
American Century Ultra® I
Price$106.58
Change-$0.29 (-0.27%)
VolumeN/A
Net Assets26.44B
RGEBX vs TWUIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGEBX vs. TWUIX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGEBX is a Buy and TWUIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. TWUIX (26.4B). RGEBX (0.00) and TWUIX (0.00) have matching dividends . RGEBX was incepted earlier than TWUIX: RGEBX (11 years) vs TWUIX (29 years). RGEBX (1.09) is less costly to investors than TWUIX (0.72). RGEBX is a more actively managed with annual turnover of: 25.00 vs. TWUIX (7.00). RGEBX has a lower initial minimum investment than TWUIX: RGEBX (250) vs TWUIX (5000000). RGEBX annual gain was more profitable for investors over the last year : 20.12 vs. TWUIX (16.66). TWUIX return over 5 years is better than : 45.66 vs. RGEBX (40.41).
RGEBXTWUIXRGEBX / TWUIX
Total Expense Ratio1.090.67163%
Annual Report Gross Expense Ratio1.090.72151%
Fund Existence11 years29 years-
Gain YTD15.3987.148215%
Front LoadN/AN/A-
Min. Initial Investment25050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets332B26.4B1,258%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.1216.66121%
Returns for 3 years49.8357.6286%
Returns for 5 years40.4145.6688%
Returns for 10 years91.53190.2348%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMAX0.26N/A
+1.15%
Powell Max Ltd
DNLI15.510.08
+0.52%
Denali Therapeutics
FRPH25.580.11
+0.43%
FRP Holdings
CNA47.71-0.30
-0.62%
CNA Financial Corp
ARTV3.11-0.50
-13.85%
Artiva Biotherapeutics Inc